Prostaglandin showed no clear difference in all‐cause mortality ( compared with placebo or standard care (low certainty).
Prostaglandin showed no clear difference in serious adverse eventsc ( compared with placebo or standard care (low certainty).
The review found no eligible studies for this question.
Prostaglandin showed no clear difference in liver retransplantation ( compared with placebo or standard care (low certainty).
Prostaglandin showed no clear difference in primary non‐function of the allograft (at up to 1 month) compared with placebo or standard care (low certainty).
Prostaglandin may leads to lower acute kidney failure requiring dialysis ( compared with placebo or standard care (low certainty).
It is very uncertain whether prostaglandin changes adverse events considered non‐serious ( compared with placebo or standard care (very low certainty).